三星医疗(601567)披露子公司签订海外经营合同,12月24日股价上涨0.09%

Core Viewpoint - Samsung Medical (601567) has signed a contract for a smart meter project in Brazil, which is expected to contribute to its revenue in 2024 [1] Group 1: Company Performance - As of December 24, 2025, Samsung Medical's stock closed at 23.16 yuan, reflecting a 0.09% increase from the previous trading day [1] - The company's total market capitalization is 32.545 billion yuan [1] - The stock opened at 23.01 yuan, reached a high of 23.43 yuan, and a low of 22.91 yuan, with a trading volume of 3.29 billion yuan and a turnover rate of 1.01% [1] Group 2: Contract Details - Samsung Medical's wholly-owned subsidiary, Brazil Nansen, has signed a contract with CPFL ENERGIA for the Brazil CPFL smart meter project [1] - The total contract amount is 10,590.99 million Brazilian Reais, approximately 135 million yuan [1] - This contract represents 0.92% of the company's audited operating revenue for the year 2024 [1] Group 3: Risks - The announcement highlights potential risks during the contract execution, including force majeure, adjustments in international trade policies, and exchange rate fluctuations [1]